Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2026/01/100056
CTRI/2026/01/100056Not yet recruitingPhase 2/3

Pharmacognostical and Clinical study evaluating the efficacy of Rudraksha seed (Elaeocarpus ganitrus Roxb) in the management of Essential Hypertension

Department of Dravyaguna Faculty of Ayurveda IMS BHU Varanasi Uttar Pradesh India1 site in 1 country108 target enrollmentStarted: March 6, 2026Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 2/3
Status
Not yet recruiting
Sponsor
Enrollment
108
Locations
1
Study OverviewStudy DesignEligibility CriteriaInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

108 participants will be selected having Stage 1 Essential hypertension. 54 participants will be given with Rudraksh seed powder 5gm OD and 54 participants will be given Ramipril 5mg OD. The difference in reduction in blood pressure will be statistically analysed.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
30.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •Patients having Stage 1 Essential Hypertension as per 8th JNC criteria Patients who are willing to participate in the study Patients with no significant change in their therapy over last 4 weeks prior to entry into the study.

Exclusion Criteria

  • •Known case of secondary hypertension e.g. Thyrotoxicosis, Renal artery stenosis, Pheochromocytoma etc.
  • •Known case of renal disease, Diabetes mellitus Known case of ventricular hypertrophy and coarctation of aorta.
  • •Known case of portal hypertension Women who were pregnant or were in the postpartum period or lactating.
  • •Any inflammatory conditions like RA, SLE, IBD, Ankylosing Spondylitis.
  • •Chronic Alcoholic and Chronic smokers Patients suffering from the systemic or serious illness like Leukemia, Chronic Kidney diseases, cirrhosis of liver, myocardial infarction, malignancy etc.
  • •Patient with evidence of any target organ damage.

Investigators

Sponsor
Department of Dravyaguna Faculty of Ayurveda IMS BHU Varanasi Uttar Pradesh India
Sponsor Class
Government medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Diksha Sharma

Institute of Medical Sciences, Banaras Hindu University

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Phase 3
Effect of Ayurvedic drug formulation on blood pressure.
CTRI/2025/04/084330PALS Limited60
Not yet recruiting
Phase 2/3
Traditional Ayurvedic Pressure-Point Therapy for Early-Stage High Blood Pressure
CTRI/2026/01/102630Dr Priyanka Gururani140
Not yet recruiting
Not Applicable
A Clinical Study to Assess the Effectiveness of Sarpagandha Extract Mansyadi Kwatha and Jaladhara Therapy in the Treatment of Essential Hypertension
CTRI/2026/01/100964Rajiv Gandhi Government Post Graduate Ayurvedic College and Hospital Paprola Himachal Pradesh30
Not yet recruiting
Not Applicable
A study on the role of Homeopathic Treatment in managing high Blood pressure in age group 25 to 45 years.
CTRI/2026/02/103482Parul Institute of Homoeopathy And Research Hospital30
Recruiting
Phase 3
The study compare how well the medicinal application over the two site of head works in reducing blood pressure in hypertension with the medicine ksirabala taila and kachuradi curna
CTRI/2024/07/069909VPSV Ayurveda college Kottakkal116